<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38736712</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-7076</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>IJID regions</Title><ISOAbbreviation>IJID Reg</ISOAbbreviation></Journal><ArticleTitle>Exploring the dynamics of COVID-19 in a Greenlandic cohort: Mild acute illness and moderate risk of long COVID.</ArticleTitle><Pagination><StartPage>100366</StartPage><MedlinePgn>100366</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100366</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijregi.2024.100366</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study aimed to explore how the Greenlandic population experienced the course of both acute and long-term COVID-19. It was motivated by the unique epidemiologic situation in Greenland, with delayed community transmission of SARS-CoV-2 relative to the rest of the world.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In a survey among 310 Greenlandic adults, we assessed the association between previous SARS-CoV-2 infection and overall health outcomes by administering three repeated questionnaires over 12 months after infection, with a response rate of 41% at the 12-month follow-up. The study included 128 individuals with confirmed SARS-CoV-2 infection from January/February 2022 and 182 test-negative controls. Participants were recruited through personal approaches, phone calls, and social media platforms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 53.7% of 162 participants who were test-positive recovered within 4 weeks and 2.5% were hospitalized due to SARS-CoV-2. The most common symptoms were fatigue and signs of mild upper respiratory tract infection. Less than 5% reported sick leave above 2 weeks after infection. Compared with participants who were test-negative, there was an increased risk of reporting fatigue (risk differences 25.4%, 95% confidence interval 8.8-44.0) and mental exhaustion (risk differences 23.4%, 95% confidence interval 4.8-42.2) up to 12 months after a positive test.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our results indicate that during a period dominated by the Omicron variant, Greenlanders experienced a mild acute course of COVID-19, with quick recovery, minimizing the impact on sick leave. Long COVID may be present in Greenlanders, with symptoms persisting up to 12 months after infection. However, it is important to consider the small sample size and modest response rate as limitations when interpreting the results.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Mie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Greenland Center for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Queen Ingrid's Hospital Nuuk, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology &amp; Prevention, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelsen</LastName><ForeName>Trine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Greenland Center for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Queen Ingrid's Hospital Nuuk, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Board of Health, Nuuk, Greenland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Anna Irene Vedel</ForeName><Initials>AIV</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology &amp; Prevention, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Lennart Friis</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Rigshospitalet University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Bispebjerg University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilling-Hansen</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Rigshospitalet University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkby</LastName><ForeName>Nikolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Rigshospitalet University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedsted</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical medicine / Public health, University of Aarhus, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ilulissat Regional Hospital, Ilulissat, Greenland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;lbak</LastName><ForeName>K&#xe5;re</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology &amp; Prevention, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Greenland Center for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Queen Ingrid's Hospital Nuuk, Nuuk, Greenland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology &amp; Prevention, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>IJID Reg</MedlineTA><NlmUniqueID>9918418183106676</NlmUniqueID><ISSNLinking>2772-7076</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arctic</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Greenland</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>4</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38736712</ArticleId><ArticleId IdType="pmc">PMC11081797</ArticleId><ArticleId IdType="doi">10.1016/j.ijregi.2024.100366</ArticleId><ArticleId IdType="pii">S2772-7076(24)00037-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID), https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition; 2022 [accessed 29 September 2023].</Citation></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. A Danish questionnaire study of acute symptoms of SARS-CoV-2 infection by variant, vaccination status, sex and age. Sci Rep. 2023;13:19863. doi: 10.1038/s41598-023-47273-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47273-8</ArticleId><ArticleId IdType="pmc">PMC10645837</ArticleId><ArticleId IdType="pubmed">37964010</ArticleId></ArticleIdList></Reference><Reference><Citation>Noahsen P, Faber LL, Isidor S, Fonager J, Rasmussen M, Hansen HL. The COVID-19 pandemic in Greenland, epidemic features and impact of early strict measures, March 2020 to June 2022. Euro Surveill. 2023;28 doi: 10.2807/1560-7917.ES.2023.28.29.2200767.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2023.28.29.2200767</ArticleId><ArticleId IdType="pmc">PMC10360370</ArticleId><ArticleId IdType="pubmed">37470739</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch A, M&#xf8;ller M, Andersen &#xc5;B. Pre-travel testing of travelers to Greenland during the COVID-19 pandemic &#x2013; formation of a screening program. Arctic Yearbook. 2023;(Specialissue):1&#x2013;5.</Citation></Reference><Reference><Citation>van Doren TP, Brown RA, Heintz R. Bioocultural perspectives of pandemics and post-pandemic population health in Alaska. Arctic Yearb Spec Issue. 2023;(Specialissue):1&#x2013;29.</Citation></Reference><Reference><Citation>Mamelund SE. Geography may explain adult mortality from the 1918&#x2013;20 influenza pandemic. Epidemics. 2011;3:46&#x2013;60. doi: 10.1016/j.epidem.2011.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2011.02.001</ArticleId><ArticleId IdType="pubmed">21420659</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Harritsh&#xf8;j LH, Gybel-Brask M, Afzal S, Kamstrup PR, J&#xf8;rgensen CS, Thomsen MK, et al. Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.02596-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02596-20</ArticleId><ArticleId IdType="pmc">PMC8091860</ArticleId><ArticleId IdType="pubmed">33574119</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13:4213. doi: 10.1038/s41467-022-31897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31897-x</ArticleId><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Gower C, Otter AD, Simmons R, Kirsebom F, Letley L, et al. Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off. medRxiv. 26 October 2021. 10.1101/2021.10.25.21264964 [Accessed 08 September 2023].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.25.21264964</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  . R Foundation for Statistical Computing; ViennaAustria: 2023. R: A Language and Environment for Statistical Computing.https://www.r-project.org/</Citation></Reference><Reference><Citation>Grembi JA, Rogawski McQuade ET. Introducing riskCommunicator: an R package to obtain interpretable effect estimates for public health. PLoS One. 2022;17 doi: 10.1371/JOURNAL.PONE.0265368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0265368</ArticleId><ArticleId IdType="pmc">PMC9292119</ArticleId><ArticleId IdType="pubmed">35849588</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiliopoulos L, S&#xf8;rensen AIV, Bager P, Nielsen NM, Hansen JV, Koch A, et al. Post-acute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study. Am J Epidemiol. 2023 doi: 10.1093/aje/kwad225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad225</ArticleId><ArticleId IdType="pmc">PMC11299024</ArticleId><ArticleId IdType="pubmed">37981717</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14 doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19 doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Regan E, Svalgaard IB, S&#xf8;rensen AIV, Spiliopoulos L, Bager P, Nielsen NM, et al. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark. Nat Commun. 2023;14:6266. doi: 10.1038/s41467-023-42048-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-42048-1</ArticleId><ArticleId IdType="pmc">PMC10560282</ArticleId><ArticleId IdType="pubmed">37805514</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, Van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023;14:6588. doi: 10.1038/s41467-023-41879-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41879-2</ArticleId><ArticleId IdType="pmc">PMC10598213</ArticleId><ArticleId IdType="pubmed">37875536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, Nissen J, Cantwell L, Schwinn M, et al. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11:13153. doi: 10.1038/s41598-021-92045-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>database.earth. Median age of Greenland, https://database.earth/population/greenland/median-age; n.d. [accessed 25 March 2024).</Citation></Reference><Reference><Citation>Blomberg B, Mohn KGI, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, &#xc1; Steig B, Gaini S, et al. Long COVID in the Faroe Islands: A longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh K, Larsen TG, Hansen CB, Hasselbalch RB, Eriksen ARR, Bundgaard H, et al. Self-reported long COVID and its association with the presence of SARS-CoV-2 antibodies in a Danish cohort up to 12 months after infection. Microbiol Spectr. 2022;10 doi: 10.1128/spectrum.02537-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02537-22</ArticleId><ArticleId IdType="pmc">PMC9769646</ArticleId><ArticleId IdType="pubmed">36350150</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm H, Ivarsdottir EV, Olafsdottir T, Thorolfsdottir R, Eythorsson E, Norland K, et al. Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control study. Commun Med (Lond) 2023;3:94. doi: 10.1038/s43856-023-00326-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-023-00326-5</ArticleId><ArticleId IdType="pmc">PMC10325957</ArticleId><ArticleId IdType="pubmed">37414856</ArticleId></ArticleIdList></Reference><Reference><Citation>Khullar D, Zhang Y, Zang C, Xu Z, Wang F, Weiner MG, et al. Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program. J Gen Intern Med. 2023;38:1127&#x2013;1136. doi: 10.1007/s11606-022-07997-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07997-1</ArticleId><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. Systematic review of the prevalence of long COVID. Open Forum Infect Dis. 2023;10:ofad233. doi: 10.1093/ofid/ofad233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen TH. Human genetics of SARS-CoV-2 infection and critical COVID-19. Clin Microbiol Infect. 2022;28:1417&#x2013;1421. doi: 10.1016/j.cmi.2022.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.022</ArticleId><ArticleId IdType="pmc">PMC8865963</ArticleId><ArticleId IdType="pubmed">35218979</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, B&#xf8;rresen ML, et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J Exp Med. 2022;219 doi: 10.1084/jem.20212427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20212427</ArticleId><ArticleId IdType="pmc">PMC9026249</ArticleId><ArticleId IdType="pubmed">35442417</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilunga FP, Appelman B, Van Vugt M, Kalverda K, Smeele P, Van Es J, et al. Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg Health Eur. 2023;29 doi: 10.1016/j.lanepe.2023.100630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId><ArticleId IdType="pmc">PMC10079482</ArticleId><ArticleId IdType="pubmed">37261215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>